Malto-oligosyltrehalose trehalohydrolase

BE0002951ProteinDeinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)treZ

Malto-oligosyltrehalose trehalohydrolase (Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422)) is a protein target in DrugBank. It is acted on by 2 drugs in DrugBank.

Gene name
treZ
UniProtKB entry
Q9RX51Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
600 residues · 66,909 Da
Also known as
3.2.1.141 · 4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase · Maltooligosyl trehalose trehalohydrolase · MTHase

Resolves to

Protein
UniProtQ9RX51UniProt nameTREZ_DEIRA
Gene
NCBI Gene1798275
Pharmacology
KEGGdra:DR_0464
Structure
PDB2BHUPDB2BHYPDB2BHZ
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Malto-oligosyltrehalose trehalohydrolase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In